Blueprint for the Development of Remyelination Medicines for Multiple Sclerosis

Clinical Neurology - Japan
doi 10.5692/clinicalneurol.50.870
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Societas Neurologica Japonica

Related search

Novel Remyelination Strategy for Multiple Sclerosis in the Era of Oligodendrocytopathy

Clinical Neurology
Neurology
2012English

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis

eNeuro
MedicineNeuroscience
2018English

Remyelination in Multiple Sclerosis: Realizing a Long-Standing Challenge

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2015English

Multiple Sclerosis CD49d+CD154+ as Myelin-Specific Lymphocytes Induced During Remyelination

Cells
2019English

Blueprint for Implementing the UN’s Sustainable Development Goals

Strategy and Leadership
ManagementStrategy
2018English

Human Monoclonal Antibodies Reactive to Oligodendrocytes Promote Remyelination in a Model of Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Biotin for Multiple Sclerosis

Pharmacy Today
2017English

Biomarkers for Multiple Sclerosis

Internal Medicine
Internal MedicineMedicine
2014English

Cannabis for Multiple Sclerosis

Practical Neurology
MedicineNeurology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy